Clinical Trial Update: Safety and Efficacy Study for a New Antiviral Drug to Treat Genital Herpes Type 2 [Phase 2]

View source ↗

Summary

Phase 2 trial update on a new antiviral for genital herpes type 2 (HSV-2) showing completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Herpes
• Herpes Simplex Virus Type Infection

Snippet

Sponsor: AiCuris Anti-infective Cures AG | Conditions: HSV-2 | Phase 2 | Status: COMPLETED | Results posted: 2022-02-04